small molecule

ELUCIREM

GADOPICLENOL

Loss of exclusivityJanuary 2040latest FDA-listed patent expiry

CompanyGuerbet →View the full company profile on CliffBio

Drug detail

Brand name	ELUCIREM
Active ingredient	GADOPICLENOL
Strength	14.553GM/30ML (485.1MG/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	September 2022
Marketing status	RX

Listed patents

Patent	Expires	Type
12064487	January 2040	use U-4424
11590246	January 2040	product
10973934	August 2039	substance
8114863	September 2028	substance

Regulatory exclusivity

Code	Expires
NPP	February 2029
NCE	September 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Guerbet